Cart
sales@molnova.com
MethADP
CAS No. 3768-14-7
MethADP( —— )
Catalog No. M33017 CAS No. 3768-14-7
MethADP (Adenosine 5'-(α,β-methylene)diphosphate) is a specific CD73 inhibitor that inhibits the enzyme ecto-5′-nucleotidase (ecto), which has been used in the study of neurological and cardiovascular diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 278 | In Stock |
|
| 5MG | 471 | In Stock |
|
| 10MG | 658 | In Stock |
|
| 25MG | 1017 | In Stock |
|
| 50MG | 1349 | In Stock |
|
| 100MG | 1823 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMethADP
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethADP (Adenosine 5'-(α,β-methylene)diphosphate) is a specific CD73 inhibitor that inhibits the enzyme ecto-5′-nucleotidase (ecto), which has been used in the study of neurological and cardiovascular diseases.
-
DescriptionMethADP is a specific CD73 inhibitor.
-
In VitroMethADP (AMP-CP: 20 μM) causes a marked inhibition of adenosine formation (0.96±0.96 μM) compared to untreated controls (9.6±1.5 μM) in A498 and RT4 cells, and MethADP (100 μM) completely inhibits the adenosine formation.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCD73
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number3768-14-7
-
Formula Weight425.23
-
Molecular FormulaC11H17N5O9P2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CN3)O[C@H](COP(CP(=O)(O)O)(=O)O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mohlin C, et al. Studies of the extracellular ATP-adenosine pathway in human urinary tract epithelial cells. Pharmacology. 2009;84(4):196-202.?
molnova catalog
related products
-
Thymidylate Kinase I...
YMU1 is a human thymidylate kinase (hTMPK) inhibitor. YMU1 stabilizes the conformation of ligand-induced degradation (LID) region of hTMPK and blocks the catalytic site or ATP-binding site.
-
Gemcitabine elaidate...
Gemcitabine elaidate (CP-4126) hydrochloride is a lipophilic pro-drug of Gemcitabine, converted to Gemcitabine by esterases for phosphorylation.
-
[Thr30]-Neuropeptide...
[Thr30]-Neuropeptide Y, human
